Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Current Cancer Drug Targets
|
December 10, 2002
Modulating cell cycle: current applications and prospects for future drug development
Hala Gali-Muhtasib, Nadine Bakkar
Cancers
|
October 3, 2019
The Role of the Cyclin Dependent Kinase Inhibitor p21<sup>cip1/waf1</sup> in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics
Samar Al Bitar, Hala Gali-Muhtasib
Molecular Carcinogenesis
|
December 29, 2006
Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status
Sahar Al-Ayyoubi, Hala Gali-Muhtasib
Current Medicinal Chemistry
|
September 9, 2016
Overview of the Formulations and Analogs in the Taxanes' Story
Farah Yassine, Elia Salibi, Hala Gali-Muhtasib
Molecules (Basel, Switzerland)
|
November 25, 2011
A journey under the sea: the quest for marine anti-cancer alkaloids
Rita Tohme, Nadine Darwiche, Hala Gali-Muhtasib
World Journal of Clinical Oncology
|
August 9, 2021
Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells
Zaynab Fatfat, Maamoun Fatfat, Hala Gali-Muhtasib
World Journal of Gastroenterology
|
August 18, 2022
Micelles as potential drug delivery systems for colorectal cancer treatment
Zaynab Fatfat, Maamoun Fatfat, Hala Gali-Muhtasib
Expert Opinion on Drug Discovery
|
March 15, 2013
Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development
Nadine Darwiche, Sara El-Banna, Hala Gali-Muhtasib
The International Journal of Biochemistry & Cell Biology
|
November 30, 2005
Thymoquinone: a promising anti-cancer drug from natural sources
Hala Gali-Muhtasib, Albert Roessner, Regine Schneider-Stock
Molecules and Cells
|
March 2, 2025
Omics technologies as powerful approaches to unravel colorectal cancer complexity and improve its management
Zaynab Fatfat, Marwa Hussein, Maamoun Fatfat, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Current Cancer Drug Targets
|
December 10, 2002
Modulating cell cycle: current applications and prospects for future drug development
Hala Gali-Muhtasib, Nadine Bakkar
Cancers
|
October 3, 2019
The Role of the Cyclin Dependent Kinase Inhibitor p21<sup>cip1/waf1</sup> in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics
Samar Al Bitar, Hala Gali-Muhtasib
Molecular Carcinogenesis
|
December 29, 2006
Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status
Sahar Al-Ayyoubi, Hala Gali-Muhtasib
Current Medicinal Chemistry
|
September 9, 2016
Overview of the Formulations and Analogs in the Taxanes' Story
Farah Yassine, Elia Salibi, Hala Gali-Muhtasib
Molecules (Basel, Switzerland)
|
November 25, 2011
A journey under the sea: the quest for marine anti-cancer alkaloids
Rita Tohme, Nadine Darwiche, Hala Gali-Muhtasib
World Journal of Clinical Oncology
|
August 9, 2021
Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells
Zaynab Fatfat, Maamoun Fatfat, Hala Gali-Muhtasib
World Journal of Gastroenterology
|
August 18, 2022
Micelles as potential drug delivery systems for colorectal cancer treatment
Zaynab Fatfat, Maamoun Fatfat, Hala Gali-Muhtasib
Expert Opinion on Drug Discovery
|
March 15, 2013
Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development
Nadine Darwiche, Sara El-Banna, Hala Gali-Muhtasib
The International Journal of Biochemistry & Cell Biology
|
November 30, 2005
Thymoquinone: a promising anti-cancer drug from natural sources
Hala Gali-Muhtasib, Albert Roessner, Regine Schneider-Stock
Molecules and Cells
|
March 2, 2025
Omics technologies as powerful approaches to unravel colorectal cancer complexity and improve its management
Zaynab Fatfat, Marwa Hussein, Maamoun Fatfat, et al.
Page
of 8